Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Aude Gaslonde has worked on the following 11 EPO patent applications which have been published in the last five years:

EP12305109

Antitumoral combination comprising cabazitaxel and cisplatin

IPC classification:
A61K 31/337, A61K 33/24, A61P 35/00
Applicant:
Aventis Pharma S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
APPLICATION REFUSED
EP12706546

ANTITUMORAL COMBINATION COMPRISING CABAZITAXEL AND CISPLATIN

IPC classification:
A61K 31/337, A61K 33/24, A61P 35/00
Applicant:
Aventis Pharma S.A.
Agent:
Aude Gaslonde, Sanofi
Agent:
Aude Gaslonde, Sanofi, S.A.
Status:
GRANT OF PATENT INTENDED
EP12172410

Method for preparing combretastatin

IPC classification:
C07C 213/10, C07C 217/84, C07C 231/16, C07C 237/08
Applicant:
Sanofi, S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10801618

COMBRETASTATIN DERIVATIVE PREPARATION METHOD

IPC classification:
C07C 237/04, C07D 263/06
Applicant:
Sanofi, S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11188684

LEPTOMYCIN DERIVATIVES

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
Sanofi, S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14150580

Anhydrous crystalline form of dimethoxy docetaxel and methods for preparing it

IPC classification:
C07D 305/14
Applicant:
Aventis Pharma S.A.
Agent:
Aude Gaslonde, Sanofi
Agent:
Aude Gaslonde, Sanofi, S.A.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13305280

Compositions and methods for analyzing histidine phosphorylation

IPC classification:
C07K 7/06, C07K 16/44, C07K 17/06
Applicant:
Sanofi, S.A.
Agent:
Aude Gaslonde, Sanofi
Agent:
Aude Gaslonde, Sanofi, S.A.
Status:
APPLICATION REFUSED
EP13717123

METHODS FOR TREATING CANCER USING PI3K INHIBITOR AND MEK INHIBITOR

IPC classification:
A61K 31/44, A61K 31/519, A61K 45/06, A61P 35/00
Applicant:
Sanofi, S.A.
Applicant:
Merck Patent GmbH
Agent:
Aude Gaslonde, Sanofi
Status:
GRANT OF PATENT INTENDED
EP13762487

CRYSTALLINE COMPOUNDS

IPC classification:
A61K 31/498, A61P 35/00, C07D 241/44
Applicant:
Sanofi, S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13762486

TABLET FORMULATION OF A PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR

IPC classification:
A61K 9/20, A61K 9/28, A61K 31/498, A61P 35/00
Applicant:
Sanofi, S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
EXAMINATION IN PROGRESS
EP15305720

CABAZITAXEL AND ITS USE FOR TREATING CANCER

IPC classification:
A61K 31/337, A61P 35/00
Applicant:
Aventis Pharma S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
APPLICATION REFUSED

Please Sign in to use this feature